Transcriptional circuits in B cell transformation

Current Opinion in Hematology

Volumn 24, Issue 4, 2017, Pages 345-352

  Hu, Yeguang ^a   Yoshida, Toshimi ^a   Georgopoulos, Katia ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

IKAROS; leukaemia; Polycomb repression; pre B cell differentiation; super enhancers

Indexed keywords

IKAROS TRANSCRIPTION FACTOR; POLYCOMB GROUP PROTEIN; PROTEIN BINDING;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SELF-RENEWAL; ENHANCER REGION; HUMAN; LYMPHOCYTE TRANSFORMATION; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; ANIMAL; B LYMPHOCYTE; CELL TRANSFORMATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PATHOLOGY;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SELF RENEWAL; CELL TRANSFORMATION, NEOPLASTIC; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; IKAROS TRANSCRIPTION FACTOR; POLYCOMB-GROUP PROTEINS; PRECURSOR CELLS, B-LYMPHOID; PROTEIN BINDING; TRANSCRIPTION, GENETIC;

EID: 85020414982     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0000000000000352     Document Type: Review

References (44)

1. Herzog S, Reth M, Jumaa H. Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling. Nat Rev Immunol 2009; 9:195-205.
2. Nutt SL, Kee BL. The transcriptional regulation of B cell lineage commitment. Immunity 2007; 26:715-725.
3. Bryder D, Sigvardsson M. Shaping up a lineage: lessons from B lymphopoesis. Curr Opin Immunol 2010; 22:148-153.
4. Mandel EM, Grosschedl R. Transcription control of early B cell differentiation. Curr Opin Immunol 2010; 22:161-167.
5. Mullighan CG, Goorha S, Radtke I, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007; 446:758-764.
6. Mullighan CG. Molecular genetics of B-precursor acute lymphoblastic leukemia. J Clin Invest 2012; 122:3407-3415.
7. Roberts KG, Morin RD, Zhang J, et al. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell 2012; 22:153-166.
8. Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. Lancet 2013; 381:1943-1955.
9. Mullighan CG, Miller CB, Radtke I, et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 2008; 453:110-114.
10. Marshall AJ, Fleming HE, Wu GE, Paige CJ. Modulation of the IL-7 doseresponse threshold during pro-B cell differentiation is dependent on pre-B cell receptor expression. J Immunol 1998; 161:6038-6045.
11. Fleming HE, Paige CJ. Pre-B cell receptor signaling mediates selective response to IL-7 at the pro-B to pre-B cell transition via an ERK/MAP kinase-dependent pathway. Immunity 2001; 15:521-531.
12. Malin S, McManus S, Cobaleda C, et al. Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development. Nat Immunol 2010; 11:171-179.
13. Corfe SA, Paige CJ. The many roles of IL-7 in B cell development; mediator of survival, proliferation and differentiation. Semin Immunol 2012; 24:198-208.
14. Yasuda T, Sanjo H, Pages G, et al. Erk kinases link pre-B cell receptor signaling to transcriptional events required for early B cell expansion. Immunity 2008; 28:499-508.
15. Kierney PC, Dorshkind K. B lymphocyte precursors and myeloid progenitors survive in diffusion chamber cultures but B cell differentiation requires close association with stromal cells. Blood 1987; 70:1418-1424.
16. Hayashi S, Kunisada T, Ogawa M, et al. Stepwise progression of B lineage differentiation supported by interleukin 7 and other stromal cell molecules. J Exp Med 1990; 171:1683-1695.
17. Rolink A, Haasner D, Nishikawa S, Melchers F. Changes in frequencies of clonable pre B cells during life in different lymphoid organs of mice. Blood 1993; 81:2290-2300.
18. Joshi I, Yoshida T, Jena N, et al. Loss of Ikaros DNA-binding function confers integrin-dependent survival on pre-B cells and progression to acute lymphoblastic leukemia. Nat Immunol 2014; 15:294-304.
19. Schwickert TA, Tagoh H, Gultekin S, et al. Stage-specific control of early B cell development by the transcription factor Ikaros. Nat Immunol 2014; 15:283-293.
20. Churchman ML, Low J, Qu C, et al. Efficacy of retinoids in IKZF1-mutated BCR-ABL1 acute lymphoblastic leukemia. Cancer Cell 2015; 28:343-356.
21. Churchman ML, Evans K, Richmond J, et al. Synergism of FAK and tyrosine kinase inhibition in Ph+ B-ALL. JCI Insight 2016; 1 (4).
22. Yoshida T, Ng SY, Zuniga-Pflucker JC, Georgopoulos K. Early hematopoietic lineage restrictions directed by Ikaros. Nat Immunol 2006; 7:382-391.
23. Ng SY, Yoshida T, Zhang J, Georgopoulos K. Genome-wide lineage-specific transcriptional networks underscore Ikaros-dependent lymphoid priming in hematopoietic stem cells. Immunity 2009; 30:493-507.
24. Hu Y, Zhang Z, Kashiwagi M, et al. Superenhancer reprogramming drives a B-cell-epithelial transition and high-risk leukemia. Genes Dev 2016; 30:1971-1990.
25. Whyte WA, Orlando DA, Hnisz D, et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 2013; 153:307-319.
26. Hnisz D, Abraham BJ, Lee TI, et al. Super-enhancers in the control of cell identity and disease. Cell 2013; 155:934-947.
27. Hnisz D, Schuijers J, Lin CY, et al. Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers. Mol Cell 2015; 58:362-370.
28. Riddell J, Gazit R, Garrison BS, et al. Reprogramming committed murine blood cells to induced hematopoietic stem cells with defined factors. Cell 2014; 157:549-564.
29. Chambers J, Rabbitts TH. LMO2 at 25 years: a paradigm of chromosomal translocation proteins. Open Biol 2015; 5:150062.
30. Yu FX, Zhao B, Guan KL. Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell 2015; 163:811-828.
31. Galli GG, Carrara M, Yuan WC, et al. YAP drives growth by controlling transcriptional pause release from dynamic enhancers. Mol Cell 2015; 60:328-337.
32. Rhee H, Polak L, Fuchs E. Lhx2 maintains stem cell character in hair follicles. Science 2006; 312:1946-1949.
33. Salvatierra J, Lee DA, Zibetti C, et al. The LIM homeodomain factor Lhx2 is required for hypothalamic tanycyte specification and differentiation. J Neurosci 2014; 34:16809-16820.
34. Adam RC, Yang H, Rockowitz S, et al. Pioneer factors govern super-enhancer dynamics in stem cell plasticity and lineage choice. Nature 2015; 521: 366-370.
35. Georgopoulos K, Moore DD, Derfler B. Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. Science 1992; 258:808-812.
36. Qian S, Capovilla M, Pirrotta V. The bx region enhancer, a distant cis-control element of the Drosophila Ubx gene and its regulation by hunchback and other segmentation genes. EMBO J 1991; 10:1415-1425.
37. Shimell MJ, Simon J, Bender W, O'Connor MB. Enhancer point mutation results in a homeotic transformation in Drosophila. Science 1994; 264:968-971.
38. Muller J, Bienz M. Sharp anterior boundary of homeotic gene expression conferred by the fushi tarazu protein. EMBO J 1992; 11:3653-3661.
39. Cheng AM, Rowley B, Pao W, et al. Syk tyrosine kinase required for mouse viability and B-cell development. Nature 1995; 378:303-306.
40. Gong S, Nussenzweig MC. Regulation of an early developmental checkpoint in the B cell pathway by Ig beta. Science 1996; 272: 411-414.
41. Minegishi Y, Rohrer J, Coustan-Smith E, et al. An essential role for BLNK in human B cell development. Science 1999; 286:1954-1957.
42. Pappu R, Cheng AM, Li B, et al. Requirement for B cell linker protein (BLNK) in B cell development. Science 1999; 286:1949-1954.
43. Cooper AB, Sawai CM, Sicinska E, et al. A unique function for cyclin D3 in early B cell development. Nat Immunol 2006; 7:489-497.
44. Dengler HS, Baracho GV, Omori SA, et al. Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation. Nat Immunol 2008; 9:1388-1398.